Webinar: Real-Time Trials are coming: Is Pharma Ready?
How clinical development is moving from periodic review to continuous intelligence and what sponsors need to do to prepare.
Clinical trials are generating more data than ever.
Most teams are still waiting weeks to act on it.
The clinical trial operating model was built for a different era. Evidence sits fragmented across EDC, CTMS, labs, safety, imaging, and IRT. Teams spend days assembling reports instead of interpreting signals. By the time insights reach the right people, the window to intervene has often closed.
In this webinar, we explore what it actually takes to move from periodic review to continuous intelligence — and what sponsors need to do to prepare.
In this webinar, we will discuss:
Why clinical teams have a time-to-action problem, not a data problem — and what that distinction means for how you build your operating model.
What the FDA's real-time clinical trials direction actually demands — and why periodic analyses and database lock can no longer be the only moments of clarity.
What continuous trial intelligence looks like in practice — including real customer results: 25% faster database lock, thousands of hours saved, and DSMB questions answered live in governance meetings.
The shift is already underway.
Patients are waiting. Join the conversation.
→ Wednesday, August 26th, 12pm CT
Speakers:
